获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍_老虎社区_美港股上老虎

获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍

老虎资讯综合2019-12-23

12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

RayMegatron
·2019-12-24
神经病可以吃药了
回复
点赞
举报
RoyYep
·2019-12-24
[微笑]
回复
1
举报
Davidsun
·2019-12-23
hl好厉害
回复
点赞
举报
收起
- 社区成长助手:
  终于等到了您的初发帖[比心]，虎妞已给你送上100虎币，请前往商城领取哦；
  希望更多虎友看到您的帖子，可以尝试用＄关联相关股票，或者发布在相关话题下面。
  此外如果您想创作优质文章，这里有一份老虎社区创作指引给到您，希望能对您有帮助！
  2019-12-23
  回复
  举报

热议股票

7x24

全部

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/1102725642?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","is_english":false,"pubTime":"2019-12-23 22:11","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1102725642","market":"us","top_or_hot":-1,"title":"获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍","media":"老虎资讯综合","content":"<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2019-12-23 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":null,"article_id":"1102725642","we_media_id":"102","thumbnails":["https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1102725642","pubTimestamp":1577110298,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"老虎资讯综合","introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"summary":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{},"translate_title":"Drug company ITCI doubled its pre-market share price after FDA approved drugs for schizophrenia.","themeId":null,"isJumpTheme":false,"ttsUrl":"https://static.tigerbbs.com/42fbffb681414baf23ff6aa5982dbe53","symbols_score_info":{},"content_text":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。","kind":"news","is_publish_news":false,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":913056985,"gmtCreate":1577125581747,"gmtModify":1704335314413,"author":{"id":"3441367527148889","authorId":"3441367527148889","name":"RayMegatron","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3441367527148889","idStr":"3441367527148889"},"htmlText":"神经病可以吃药了","listText":"神经病可以吃药了","text":"神经病可以吃药了","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/913056985","repostId":1102725642,"repostType":2,"repost":{"id":"1102725642","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1577110298,"share":"https://www.laohu8.com/m/news/1102725642?lang=&edition=full","pubTime":"2019-12-23 22:11","market":"us","language":"zh","title":"获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1102725642","media":"老虎资讯综合","summary":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙","content":"<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2019-12-23 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102725642","content_text":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":913024143,"gmtCreate":1577120211482,"gmtModify":1704335305684,"author":{"id":"13599073574816","authorId":"13599073574816","name":"RoyYep","avatar":"https://static.tigerbbs.com/3bb564ed2d3a08d4a948e2194f62a83a","vip":1,"crmLevel":2,"crmLevelSwitch":1,"authorIdStr":"13599073574816","idStr":"13599073574816"},"htmlText":"[微笑]&nbsp;","listText":"[微笑]&nbsp;","text":"[微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/913024143","repostId":1102725642,"repostType":2,"repost":{"id":"1102725642","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1577110298,"share":"https://www.laohu8.com/m/news/1102725642?lang=&edition=full","pubTime":"2019-12-23 22:11","market":"us","language":"zh","title":"获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1102725642","media":"老虎资讯综合","summary":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙","content":"<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2019-12-23 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102725642","content_text":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":913083253,"gmtCreate":1577113615972,"gmtModify":1704335273959,"author":{"id":"3491212147730512","authorId":"3491212147730512","name":"Davidsun","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/e6295840391b9cdc17115677ba51429c","crmLevel":1,"crmLevelSwitch":0,"authorIdStr":"3491212147730512","idStr":"3491212147730512"},"htmlText":"hl好厉害","listText":"hl好厉害","text":"hl好厉害","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/913083253","repostId":1102725642,"repostType":2,"repost":{"id":"1102725642","kind":"news","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1577110298,"share":"https://www.laohu8.com/m/news/1102725642?lang=&edition=full","pubTime":"2019-12-23 22:11","market":"us","language":"zh","title":"获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍","url":"https://stock-news.laohu8.com/highlight/detail?id=1102725642","media":"老虎资讯综合","summary":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙","content":"<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n获FDA批准治疗精神分裂症药物，药企ITCI盘前股价翻倍\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2019-12-23 22:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><span>12月23日讯，美国食品药品监督管理局（FDA）周一批准了$<a href=\"https://laohu8.com/S/ITCI\">Intra-Cellular Therapies Inc.</a>(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。</span></p><p><img src=\"https://static.tigerbbs.com/38ee9be9801926d169258f2b40ddd199\" /></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/3c6daacf13f78492ec38a4e178ddca49","relate_stocks":{},"is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1102725642","content_text":"12月23日讯，美国食品药品监督管理局（FDA）周一批准了$Intra-Cellular Therapies Inc.(ITCI)$ 治疗精神分裂症的研究药物Caplyta，受此影响，该公司股价盘前飙升99.36%。该公司计划在全球范围内自行推出该药物。","news_type":1,"symbols_score_info":{}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":2024170,"gmtCreate":1577113773236,"gmtModify":1577113773236,"authorId":3527667803686145,"author":{"id":3527667803686145,"idStr":"3527667803686145","authorId":3527667803686145,"name":"社区成长助手","avatar":"https://static.tigerbbs.com/2b7c7106b5c0c8b0037faa67439d898f","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":913083253,"type":1,"supId":0,"prevId":0,"content":"终于等到了您的初发帖[比心]，虎妞已给你送上100虎币，请前往商城领取哦；<br>希望更多虎友看到您的帖子，可以尝试用＄关联相关股票，或者发布在相关话题下面。<br>此外如果您想创作优质文章，这里有一份<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>给到您，希望能对您有帮助！","text":"终于等到了您的初发帖[比心]，虎妞已给你送上100虎币，请前往商城领取哦；<br>希望更多虎友看到您的帖子，可以尝试用＄关联相关股票，或者发布在相关话题下面。<br>此外如果您想创作优质文章，这里有一份<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>给到您，希望能对您有帮助！","html":"终于等到了您的初发帖[比心]，虎妞已给你送上100虎币，请前往商城领取哦；<br>希望更多虎友看到您的帖子，可以尝试用＄关联相关股票，或者发布在相关话题下面。<br>此外如果您想创作优质文章，这里有一份<a href=\"https://laohu8.com/TW/934879903\">老虎社区创作指引</a>给到您，希望能对您有帮助！"}],"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":3,"commentSize":3,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"isCrawlerRequest":true}